Tuesday, February 28, 2017

Connecting the Dots - Souped-Up Food Production: The Next Big Thing? - btbirkett@gmail.com - Gmail



http://www.mauldineconomics.com/connecting-the-dots/souped-up-food-production-the-next-big-thing#

It appears to be getting closer. From the February 13 edition of the Wall Street Journal:
In a renovated warehouse by San Francisco Bay, plastic towers sprouting heads of lettuce, arugula, and herbs rise 20 feet to the ceiling, illuminated by multicolored LED lights that give the room a futuristic feel.
A group of tech entrepreneurs and investors including billionaires Jeff Bezos and Eric Schmidt are betting this facility, 100 miles north of California’s “salad bowl” produce-farming epicenter, can redefine how vegetables and fruits are grown for local consumption.
If all goes to plan, the 51,000-square-foot warehouse run by startup Plenty United Inc. will yield as much as 3 million pounds of leafy greens each year. In the coming months, the company plans to begin marketing produce bred for local tables rather than shipping durability.
This is a prototype operation, still a long way from being feasible at scale. The article reviews some of the challenges. But if it works, the economic consequences will be staggering.

JPMorgan Marshals an Army of Developers to Automate High Finance - Bloomberg

JPMorgan Marshals an Army of Developers to Automate High Finance - Bloomberg



...The program, called COIN, for Contract Intelligence, does the mind-numbing job of interpreting commercial-loan agreements that, until the project went online in June, consumed 360,000 hours of work each year by lawyers and loan officers. The software reviews documents in seconds, is less error-prone and never asks for vacation....

...Machine learning and big-data efforts now reside on the private platform, which effectively has limitless capacity to support their thirst for processing power. ...



...JPMorgan’s total technology budget for this year amounts to 9 percent of its projected revenue -- double the industry average,...




Buckle Up for Rapid Growth - Bloomberg View

Buckle Up for Rapid Growth - Bloomberg View

Monday, February 27, 2017

Fed Turns to Job Hoppers - Bloomberg

https://www.bloomberg.com/news/articles/2017-02-27/fed-turns-to-job-hoppers-as-1950s-inflation-guide-shows-its-age

...And according to the Atlanta Fed’s wage tracker, which monitors wages of continuously employed workers, Americans who are willing to change jobs do benefit. The data showed job switchers earned 4.3 percent more money in July 2016 than a year earlier, while people who remained in the same job enjoyed only a 3 percent increase....

...That doesn’t mean that people like her are fueling inflation during tight labor markets, as they often receive better compensation only when their productivity increases, according to Giuseppe Moscarini, a Yale University professor and visiting scholar at the Philadelphia Fed. In fact, Heintz said her raises came with increased responsibility at jobs that better match her skills.
“What we should worry about are wage raises for workers who stay on the same job and are not getting more productive,” according to Moscarini.

Sunday, February 26, 2017

Solar Squabble Shows How a Trump Trade War With China Could Backfire - Bloomberg

Solar Squabble Shows How a Trump Trade War With China Could Backfire - Bloomberg



...After the U.S. slapped duties on Chinese solar panel exports in 2011, China shot back about a year later with measures against the American polysilicon exports used to make those units. Along with other producers in the U.S., REC Silicon, a Norwegian company which produces the material at factories in Moses Lake, Washington and Butte, Montana, was clobbered....





...The fix: opening a $1 billion joint venture factory in the central Chinese city of Yulin that’ll employ up to 650 workers.

Tech Digest - Trump's Murder by Pharma Comment Should Be Taken Seriously - btbirkett@gmail.com - Gmail

Tech Digest - Trump's Murder by Pharma Comment Should Be Taken Seriously - btbirkett@gmail.com - Gmail



Patrick Cox's Tech Digest
More Information
Tech Digest Archive »
Transformational Technologies Site »
Premium Newsletter »
January 16, 2017
Trump’s Murder by Pharma Comment Should Be Taken Seriously

Dear Reader,
Last week, Donald Trump complained about drug prices in a press conference. Drug companies, he said, are “getting away with murder.” During that presser, pharma and biotech stocks lost over $20 billion in value. Investors should have learned an important lesson. They probably didn’t.
Trump’s targeting of drug sellers was not a fluke. Hillary Clinton’s “price gouging” tweet last September had a similar impact on markets. For those who understand the big picture, these two events offer clues about the future of the drug business.

The real problem isn’t drug prices

The big picture is relatively simple. Healthcare costs will continue to rise even if drug prices go down. At most, medicines account for about 15% of the national medical bill. They’re not the reason that costs are rising, but they are easier to attack than hospitals and doctors.
Here’s the real problem: America is broke. Worse than broke, actually. This is because of healthcare costs. These costs are the number one driver of federal spending (as well as the deficit and debt). As President Obama learned, those costs are hardcoded into the system.
Healthcare costs are rising not because of greed or inefficiency (though there are plenty of both). They’re rising for demographic reasons. And they’re rising faster than our ability to repay the trillions we’ve already borrowed. The unfunded liabilities for future healthcare are even more of a problem.
As a result, our fiscal policy choices will be increasingly limited and ineffectual. Politicians and the public will demand that “something be done.” That something will include even greater government involvement in drug pricing.
Let me explain why this is inevitable. As the CBO has pointed out, age-related healthcare costs and the associated debt service are the only part of the federal budget that’s growing in proportion to the whole. (Increases of approximately 9% in these programs are mandatory and automatic.)
The graph above is quite sobering, but you should read the CBO’s explanation below it. Note that “growth in the major health care programs… and Social Security is projected to exceed the decline in other noninterest spending relative to GDP.”

Here’s why healthcare costs are rising

The CBO clearly points to age-related disease as the culprit. Simply put, people are living longer. Healthcare costs rise exponentially with age, and the percentage of the population that is older is growing. This is simple arithmetic, but our leaders are largely in denial over this macroeconomic reality.
This graph based on data from the HHS Administration on Aging makes the trend clear.
This aging of the population is only one half of a bigger change… often called the flipping of the demographic pyramid. It’s taking place throughout the world. But the trend is growing fastest in the West.

The effect of the baby bust

In the past, when birthrates were higher, longer life spans and a larger aged population wouldn’t have been a problem. Today though, birthrates are too low to provide the younger workers that we need to pay for our increase in medical costs.
In fact, CDC data show that the US fertility rate fell last year to its lowest since 1909 when tracking began. This puts our fertility rate at about 1.8 births per woman. At least 2.1 births are required to replace the existing population and maintain the old-age dependency ratio (OADR).
In other words, the pool of younger workers (contributors) is shrinking… while the aged population (dependents) is growing. Our already untenable OADR is getting worse.
Optimists predict that the birthrate will rise when the economy improves. It may to some degree, but US birthrates have been well below replacement rate since 1972. This is true even among immigrants. This interactive chart by the WHO shows just how dire the picture is.
Even if by some miracle, we could return to 1950s birthrates, it wouldn’t help. Why not? Babies born now won’t become working contributors for decades. Likewise, most immigrants don’t become net contributors for decades either.
The problem is that we don’t have decades to fix the problem.

The politics of the demographic shift

The political consequences of this change are huge and largely unrecognized. We can’t afford to pay the rising cost of healthcare for the aged. Nor is it possible (politically) to reduce their level of care.
We hear pundits talk a lot about the changes in political demographics. But most make the mistake of focusing on ethnicities. As such, they ignore the biggest demographic change in history—the growth of the most powerful of all political blocs… the aged. The proverbial third rail will not go quietly into the night. So politicians will try anything to put off the day of reckoning.
Most investors and politicians don’t get it. Many are in full denial. But it’s time to face facts; we’re entering the Trumpian age of the deal. Big pharma’s ability to set prices will give way to political pressures.

The future outlook for pharma

There are ways to deal with this situation… and even profit from it.
One is to shift from big pharma, ETFs, and companies that sell older existing drugs and invest in biotech startups. Big pharma will claim that reduced profits on widely used drugs will limit their ability to acquire new drugs. But it may, in fact, incentivize drug discovery.
Pharma tends to be slow to replace very profitable drugs with something newer and better. The Trump Administration could make new drug development more attractive by following through on its promise to reduce regulatory hurdles. 
Though it’s counterintuitive, new and better drugs can reduce total healthcare spending, not just drug costs. A significantly superior cancer drug, for example, would cut hospital and physician costs.
Even more exciting is the work in geroprotectors. These are drugs that could prevent (rather than treat) cancers and other age-related diseases. But these drugs are particularly difficult to approve because prevention may take decades to prove with finality.
If I were Trump, I would reach out directly to the aged community. He could enlist their help to move the most promising and safest geroprotectors into the market. There are compounds, currently stalled by regulators, that have shown incredible efficacy in animals. I believe they will effectively rejuvenate older individuals and return some degree of health and vigor. Since most people are forced to retire due to their or their spouse’s health, this could repair the dependency ratio.
A more immediate solution has appeared, ironically, in the company that inspired the fateful Clinton tweet, KaloBio. You may recall that “pharma bro” Martin Shkreli acquired control of the company and then increased the price of KaloBio’s older antibiotic Daraprim by more than 5,000%. (Daraprim is a life saver for a few thousand Americans who suffer from the parasitic disease toxoplasmosis.)
After Shkreli destroyed the company, despoiled investors looked for help. They chose industry veteran Cameron Durrant PhD, a well-known critic of big pharma. Despite initial hesitance, Durrant has since turned the company around via regulatory jiu-jitsu.
Exploiting the bad press surrounding KaloBio and the biotech industry, he announced a bold new approach to drug pricing. Called the Responsible Pricing Model, it is a transparent process that involves help and advice from those who want affordable drugs. This includes regulators, insurers, researchers, and patients. In return, KaloBio has lower costs and risks.
This approach can shift traditionally risky biotech stocks into more bond-like instruments that could outperform ETFs. Bigger pharma players, including Allergan, are now emulating Durrant’s approach.
Clearly, the industry is starting to see the writing on the wall. Investors should as well.

Outside the Box - Fed Up - btbirkett@gmail.com - Gmail

Outside the Box - Fed Up - btbirkett@gmail.com - Gmail



....

Culture Shock

“If it were possible to take interest rates into negative territory, I would be voting for that.”
– Janet Yellen, February 2010

As her fame has grown, Janet Yellen is recognized in restaurants and airports around the world. But her world has narrowed. Because the Fed chairman can so easily move markets with a few casual words, Yellen can’t get together regularly and shoot the breeze with businesspeople or analysts who follow the Fed for a living. She must rely on her instincts, her Keynesian training, and the MIT Mafia.

“You can’t think about what is happening in the economy constructively, from a policy standpoint, unless you have some theoretical paradigm in mind,” Yellen had told Lemann of the New Yorker in 2014.

One of Lemann’s final observations: “The Fed, not the Treasury or the White House or Congress, is now the primary economic policymaker in the United States, and therefore the world.”

But what if Yellen’s theoretical paradigm is dead wrong?
The woman who “did not see and did not appreciate what the risks were with securitization, the credit rating agencies, the shadow banking system, the SIVs ... until it happened” has led us straight into an abyss.

It’s time to climb out. The Federal Reserve’s leadership must come to grips with its role in creating the extraordinary circumstances in which it now finds itself. It must embrace reforms to regain its credibility.

Even Fedwire finally admitted in August 2016 that the Federal Reserve had lost its mojo, with a story headlined “Years of Fed Missteps Fueled Disillusion with the Economy and Washington.” In an effort to explain rising extremism in American politics in a series called “The Great Unraveling,” Jon Hilsenrath described a Fed confronting “hardened public skepticism and growing self-doubt.”

Mistakes by the Fed included missing the housing bubble and financial crisis, being “blinded” to the slowdown in the growth of worker productivity, and failing to anticipate how inflation behaved in regard to the job market. The Fed’s economic projections of GDP and how fast the economy would grow were wrong time and again.

People are starting to wake up. A Gallup poll showed that Americans’ confidence that the Fed was doing a “good” or “excellent” job had fallen from 53 percent in September 2003 to 38 percent in November 2014. Another poll in April 2016 showed that only 38 percent of Americans had a great deal or fair amount of confidence in Yellen, while 35 percent had little or  none – a huge shift from the early 2000s when 70 percent and higher expressed confidence (however misguided) in Greenspan.

In early 2016, Yellen told an audience in New York that it was too bad the government had leaned so heavily on the Fed while “tax and spending policies were stymied by disagreements between Congress and the White House.” Maybe if she hadn’t been throwing money at them, lawmakers might have gotten their house in order.

“The Federal Reserve is a giant weapon that has no ammunition left,” Fisher told CNBC on January 6, 2016.

The Fed must retool and rearm.

First things first. Congress should release the Fed from the bondage of its dual mandate.
A singular focus on maintaining price stability will place the duty of maximizing employment back into the hands of politicians, making them responsible for shaping fiscal policy that ensures American businesses enjoy a traditionally competitive landscape in which to build and grow business.

The added bonus: shedding the dual mandate will discourage future forays into unconventional monetary policy.

Next, the Fed needs to get out of the business of trying to compel people to spend by manipulating inflation expectations. Not only has it introduced a dangerous addiction to debt among all players in the economy, it has succeeded in virtually outlawing saving.

Most seniors pine for a return to the beginning of this century when they could get a five-year jumbo CD with a 5 percent APR, offset by inflation somewhere in the neighborhood of 2 percent. Traditionally, 2 to 3 percentage points above inflation is where that old relic, the fed funds rate, traded. The math worked.

Under ZIRP, only fools save for a rainy day. The floor on overnight rates must be permanently raised to at least 2 percent and Fed officials should pledge to never again breach that floor. Not only will it preserve the functionality of the banking system, it will remind people that saving is good, indeed a virtue. And that debt always has a price.

Limit the number of academic PhDs at the Fed, not just among the leadership but on the staffs of the Board and District Banks. Bring in more actual practitioners – businesspeople who have been on the receiving end of Fed policy, CEOs and CFOs, people who have been on the hot seat, who have witnessed the financialization of the country and believe that American companies should make things and provide services, not just move money around.
Governors should be given terms of five years, like District Bank presidents, with term limits to bring in new blood and fresh ideas.

Grant all the District Bank presidents, not just New York’s, a permanent vote on the FOMC. Why should Wall Street, not Main Street, dominate the Fed’s decision making?
While we’re at it, let’s redraw the Fed’s geographical map to better reflect America’s economic powerhouses.

California’s economy alone is the sixth biggest in the world. Add another Fed Bank to the Twelfth District to better represent how the Western states have flourished over the last hundred years.

Why does Missouri have two Fed banks? Minneapolis and Cleveland can be absorbed into the Chicago Fed. Do Richmond, Philadelphia, and Boston all need Fed District Banks? Consolidate in recognition of the fact that it isn’t 1913 anymore.

Slash the Fed’s bloated Research Department. It’s hard to argue that a thousand Fed economists are productive and providing value-added insight when their forecasting skills are no better than the flip of a coin and half of their studies cannot be replicated.

Send most of the PhD economists back to academia where they belong. Require the rest to focus on research that benefits the Fed, studying how its policies impact American taxpayers and citizens. (Did the Fed do any studies about how ZIRP and QE would impact banking and consumers before it imposed them? No.)

Now take all the money you’ve saved and aim it squarely at Wall Street investment banks intent on always staying one step ahead of the Fed’s regulatory reach. Hire brilliant people for the Fed’s Sup & Reg departments and pay them market rates. Rest assured this will be ground zero of the next crisis.

And mix it up. One of Rosenblum’s students applied for a job at the New York Fed. He came from a blue-collar background, spent seven years in the military, and earned his MBA from SMU on the GI Bill. Smart guy. But he couldn’t get to first base at the New York Fed. They hire people from Yale and Harvard and NYU – people just like themselves. Others need not apply.

Then the top Ivy Leaguers stay for two years and move on to bigger money at Citibank or Goldman Sachs. It’s a tribe that’s been bred over ninety years and slow to change.
But if the culture of extreme deference at the New York Fed (which also exists in District Banks to a lesser degree) is not quashed, regulatory capture will continue with disastrous results. The Fed must give bank examiners the resources they need to understand the ever-evolving financial innovations created by Wall Street and back them up when they challenge high-paid bankers who live to skirt the rules.

Regulators must focus on the big picture as well as nodes of risk. Interconnectedness took down the economy in 2008, not just the shenanigans of a few rogue banks.

Focus on systemic risk and regulation around the FOMC table. Create a post with equal power and authority to that of the chair to focus on supervision and regulation. Yellen talks about monetary policy ad nauseam, but when challenged by the press or Congress on regulatory policy she stumbles and mumbles and does her best doe-in-the-headlights impersonation. Markets need predictability and transparency when it comes to Fed policy, not guesswork, parsing of the chair’s words, and manipulation of FOMC minutes.

Finally, let nature take its course. Reengage creative destruction. Markets by their nature are supposed to be volatile. Zero interest rates prevent the natural failures of weak companies, weighing down the economy with overcapacity for generations.

Recessions might have been more frequent, the financial losses greater for some, but if the Fed had let the economy heal on its own, America would have been stronger in the end and the bedrock of our nation, capitalism, would not have been corrupted.

I could never have imagined how my near decade-long journey at the Federal Reserve would play out.

In the beginning, I had been a “risk radar” to benefit myself and those closest to me. I wanted to stay out of debt and make certain that my children had great educations and a foundation of financial savvy so that they could pursue their versions of the American dream.

But I realize now the stakes are much higher.

We’ve become a nation of haves and have-nots thanks to Fed policies that benefit the wealthiest investors, punish the savers and the retired, and put the nation’s balance sheet at risk.

As consumers on the receiving end of Fed policies, we must reform our education system so that the American dream can be accessible to everyone. We must campaign for Congress to stop hiding behind the Fed’s skirts.

And we must demand that the Fed stop offering excuse after excuse for its failures.  Short-term interest rates must return to some semblance of normality and the Fed’s outrageously swollen balance sheet must shrink in size. And most of all, the Fed must never follow Europe by taking interest rates into negative territory.

No more excuses. The Fed’s mandate isn’t to have a perfect world. That only exists in fairy tales, dreams, and the Fed’s econometric models.